← All themes

Medical Devices & Diagnostics

Medical devices and diagnostics are the hardware of medicine — implants, surgical robots, imaging, and the tests that decide what treatment follows. Approval and reimbursement matter to the investment case as much as the technology does.

342 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
1	1 Johnson & Johnson JNJ $612B	1,793	+1,793	–	$162B
2	2 Abbott ABT $178B	1,330	+1,330	–	$36.3B
3	3 Medtronic MDT $121B	981	+981	–	$40.9B
4	4 Baxter International BAX $12.8B	897	+897	–	$30.4B
5	5 Becton Dickinson BDX $51.5B	796	+796	–	$15.9B
6	6 Danaher DHR $158B	779	+779	–	$34.4B
7	7 DuPont de Nemours DD $17.4B	773	+773	–	$27.1B
8	8 Stryker SYK $108B	751	+751	–	$17B
9	9 Zimmer Biomet ZBH $17.5B	638	+638	–	$10.9B
10	10 Agilent Technologies A $49.1B	518	+518	–	$11.9B
11	11 Intuitive Surgical ISRG $148B	505	+505	–	$18.6B
12	12 Labcorp LH $25.7B	494	+494	–	$9.44B
13	13 Roper Technologies ROP $36.9B	426	+426	–	$11.4B
14	14 Quest Diagnostics DGX $25.8B	423	+423	–	$9.1B
15	15 Boston Scientific BSX $62.3B	410	+410	–	$11B
16	16 Waters Corp WAT $42.9B	409	+409	–	$8B
17	17 Henry Schein HSIC $9.54B	378	+378	–	$7.67B
18	18 Edwards Lifesciences EW $49.8B	375	+375	–	$6.87B
19	19 Dentsply Sirona XRAY $1.68B	374	+374	–	$5.44B
20	20 Bausch Health BHC $2.2B	356	+356	–	$23.7B
21	21 DELISTED Hologic HOLX	348	+348	–	$5.05B
22	22 ResMed RMD $33.1B	313	+313	–	$3.93B
23	23 Revvity RVTY $17B	284	+284	–	$3.28B
24	24 3D Systems Corp DDD $487M	273	+273	–	$2.61B
25	25 Cooper Companies COO $10.4B	267	+267	–	$5.56B